The pharmaceutical landscape is witnessing a change with the introduction of GLP-1 transdermal systems . These innovative formulations offer a potential alternative to providing glucagon-like peptide-1 https://rebeccatadk702465.blogerus.com/62907538/glp-1-patches-a-novel-way-to-manage-blood-sugar